(1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide

C33H41N5O3 — CID 25141903

IUPAC(1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide
SMILESO=C(NCCCN1CCN(Cc2ccccc2)C1=O)C1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
InChIInChI=1S/C33H41N5O3/c39-29-12-11-23-21-37-16-13-25-24-9-4-5-10-27(24)35-31(25)28(37)19-26(23)30(29)32(40)34-14-6-15-36-17-18-38(33(36)41)20-22-7-2-1-3-8-22/h1-5,7-10,23,26,28-30,35,39H,6,11-21H2,(H,34,40)/t23-,26-,28-,29-,30?/m0/s1
InChIKeyQUYWINUEODDMEC-XNMCOCNWSA-N
MW555.72 g/mol
LogP3.92
Rot. Bonds7

About (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide

(1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide (PubChem CID 25141903) has the molecular formula C33H41N5O3 and a molecular weight of 555.72 g/mol. Its IUPAC name is (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide.

Molecular Properties

Compound Name(1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide
PubChem CID25141903
Molecular FormulaC33H41N5O3
Molecular Weight555.72 g/mol
Exact Mass555.32
IUPAC Name(1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide
SMILESO=C(NCCCN1CCN(Cc2ccccc2)C1=O)C1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
InChIInChI=1S/C33H41N5O3/c39-29-12-11-23-21-37-16-13-25-24-9-4-5-10-27(24)35-31(25)28(37)19-26(23)30(29)32(40)34-14-6-15-36-17-18-38(33(36)41)20-22-7-2-1-3-8-22/h1-5,7-10,23,26,28-30,35,39H,6,11-21H2,(H,34,40)/t23-,26-,28-,29-,30?/m0/s1
InChIKeyQUYWINUEODDMEC-XNMCOCNWSA-N
XLogP3.92
TPSA91.91 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500555.72
LogP ≤ 53.92
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide?
The IUPAC name of (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide (CID 25141903) is (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide.
What is the SMILES notation for (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide?
The canonical SMILES for (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide is O=C(NCCCN1CCN(Cc2ccccc2)C1=O)C1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O.
What is the InChIKey of (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide?
The InChIKey is QUYWINUEODDMEC-XNMCOCNWSA-N. The full InChI is InChI=1S/C33H41N5O3/c39-29-12-11-23-21-37-16-13-25-24-9-4-5-10-27(24)35-31(25)28(37)19-26(23)30(29)32(40)34-14-6-15-36-17-18-38(33(36)41)20-22-7-2-1-3-8-22/h1-5,7-10,23,26,28-30,35,39H,6,11-21H2,(H,34,40)/t23-,26-,28-,29-,30?/m0/s1.
What are the key properties of (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide?
(1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide has a molecular weight of 555.72 g/mol, XLogP of 3.92, 7 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,15R,18S,20S)-N-[3-(3-benzyl-2-oxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide is sourced from PubChem (CID 25141903), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).